tility of continuous glucose monitoring (CGMS) in children with type I diabetes on intensive treatment regimens

Not Applicable

Completed

• Conditions: Diabetes; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN28387915
• Lead Sponsor: Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead

Brief Summary

Results in http://www.ncbi.nlm.nih.gov/pubmed/16801571

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2004-09-30
• Study Start: 2005-02-09
• Last Update Posted: 3 February 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

Children and adolescents aged 18 years or less with type one diabetes on either an insulin pump or an intensive insulin plan that includes insulin glargine (Lantus) for at least 3 months.

Exclusion Criteria

1. Known poor compliance
2. HbA1c greater than 10%

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diabetes control, measured using HbA1c and fructosamine measured at baseline and 6 and 12 weeks.

Secondary Outcome Measures

Name	Time	Method
<br> 1. HbA1c, measured using ion-exchange high-pressure liquid chromatography (Bio-Rad Laboratories)<br> 2. Fructosamine, measured using Cobras Integras system<br>